Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial

More about Open Access at the Crick

Authors list

Molebogeng X Rangaka Robert Wilkinson Andrew Boulle Judith R Glynn Katherine Fielding Gilles van Cutsem Katalin Wilkinson Rene Goliath Shaheed Mathee Eric Goemaere Gary Maartens
Scroll for detail on labs, facilities & authors

Abstract

Antiretroviral therapy reduces the risk of tuberculosis, but tuberculosis is more common in people with HIV than in people without HIV. We aimed to assess the effect of isoniazid preventive therapy on the risk of tuberculosis in people infected with HIV-1 concurrently receiving antiretroviral therapy.

Journal details

Journal Lancet
Volume 384
Issue number 9944
Pages 682-690
Publication date

Full text links

Publisher website (DOI) 10.1016/s0140-6736(14)60162-8
Europe PubMed Central 24835842
Pubmed 24835842

Keywords

Type of publication